Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

lisavanbulin (BAL101553)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Basilea

Drug class:

Apoptosis stimulant, Vascular disrupting agent, Microtubule destabilizing agent

Related drugs:

‹

›

MGMT unmethylation	Glioblastoma	MGMT unmethylation	Glioblastoma	BAL101553 Sensitive: C3 – Early Trials BAL101553 Sensitive : C3	BAL101553 Sensitive: C3 – Early Trials BAL101553 Sensitive : C3
IDH2 mutation + MYC amplification + MAPRE1 overexpression	Glioblastoma	IDH2 mutation + MYC amplification + MAPRE1 overexpression	Glioblastoma	BAL101553 Sensitive: C4 – Case Studies BAL101553 Sensitive : C4	BAL101553 Sensitive: C4 – Case Studies BAL101553 Sensitive : C4
IDH1 mutation + MYC amplification + MAPRE1 overexpression	Glioblastoma	IDH1 mutation + MYC amplification + MAPRE1 overexpression	Glioblastoma	BAL101553 Sensitive: C4 – Case Studies BAL101553 Sensitive : C4	BAL101553 Sensitive: C4 – Case Studies BAL101553 Sensitive : C4